HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rudolf Fahlbusch Selected Research

Craniopharyngioma (Craniopharyngiomas)

1/2018Characterization of the murine orthotopic adamantinomatous craniopharyngioma PDX model by MRI in correlation with histology.
11/2017Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue.
1/2017Intraoperative magnetic resonance imaging in pediatric neurosurgery: safety and utility.
12/2016Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
1/2016EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts.
10/2015BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts.
1/2014Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.
2/2012Results after treatment of craniopharyngiomas: further experiences with 73 patients since 1997.
7/2011EGFR signaling regulates tumor cell migration in craniopharyngiomas.
9/2010Hormone receptor expression in craniopharyngiomas: a clinicopathological correlation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rudolf Fahlbusch Research Topics

Disease

33Neoplasms (Cancer)
11/2018 - 01/2000
17Craniopharyngioma (Craniopharyngiomas)
01/2018 - 07/2003
8Pituitary Neoplasms (Pituitary Adenoma)
10/2018 - 01/2003
8Glioma (Gliomas)
01/2017 - 08/2004
6Adenoma (Adenomas)
11/2018 - 01/2000
5Brain Neoplasms (Brain Tumor)
01/2015 - 02/2003
4Acromegaly
10/2018 - 12/2004
4Central Nervous System Cysts (Suprasellar Cyst)
01/2016 - 06/2005
4Meningioma (Meningiomas)
03/2010 - 02/2002
3Pituitary ACTH Hypersecretion
01/2008 - 12/2004
2Growth Hormone-Secreting Pituitary Adenoma
10/2018 - 12/2004
2Residual Neoplasm
10/2018 - 08/2004
2Cysts
06/2005 - 02/2003
2Prolactinoma (Prolactinomas)
12/2004 - 01/2000
1Hydrocephalus (Hydrocephaly)
06/2017
1Oxyphilic Adenoma (Oncocytoma)
04/2017
1Hyponatremia
11/2015
1Inappropriate ADH Syndrome (SIADH)
11/2015
1Giant Cell Arteritis (Horton Disease)
07/2015
1Glaucoma
07/2015
1Disease Progression
02/2012
1Colorectal Neoplasms (Colorectal Cancer)
05/2010
1Neoplasm Metastasis (Metastasis)
03/2010
1Cavernous Hemangioma (Cavernous Angioma)
03/2010
1Neuroepithelial Neoplasms (Gliomatosis Cerebri)
03/2010
1Hyperprolactinemia
07/2009

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
11/2015 - 01/2000
5beta CateninIBA
05/2010 - 06/2005
4Hormones (Hormone)IBA
09/2010 - 01/2002
3Pharmaceutical PreparationsIBA
01/2018 - 05/2006
3CateninsIBA
01/2015 - 07/2011
3ProlactinIBA
07/2009 - 01/2000
3Protons (Proton)IBA
03/2006 - 10/2004
2Insulin-Like Growth Factor I (IGF-1)IBA
10/2018 - 08/2005
2ErbB Receptors (EGF Receptor)IBA
12/2016 - 07/2011
2Monoclonal AntibodiesIBA
10/2015 - 01/2003
2ParaffinIBA
12/2014 - 01/2003
2fascinIBA
07/2011 - 05/2010
2Growth Hormone (Somatotropin)IBA
09/2010 - 07/2009
2AntibodiesIBA
03/2010 - 01/2003
2enhanced green fluorescent proteinIBA
05/2006 - 04/2005
2Histone Deacetylases (Histone Deacetylase)IBA
05/2006 - 05/2005
2Choline (Choline Chloride)IBA
10/2004 - 08/2004
2N-acetylaspartate (N-acetyl aspartate)IBA
10/2004 - 08/2004
2CreatineIBA
10/2004 - 08/2004
1Transcription Factors (Transcription Factor)IBA
11/2018
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
10/2018
1thiamine triphosphorate (TTP)IBA
01/2018
1Octreotide (Sandostatin)FDA LinkGeneric
12/2017
1SOX Transcription FactorsIBA
11/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2017
1AntigensIBA
04/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2016
1SurvivinIBA
12/2016
1Epithelial Cell Adhesion MoleculeIBA
01/2016
1GSK-2816126IBA
11/2015
1Antidiuretic Hormone Receptor AntagonistsIBA
11/2015
1Vasopressins (Vasopressin)IBA
11/2015
1Sodium ChlorideFDA LinkGeneric
11/2015
1TolvaptanFDA Link
11/2015
1EpitopesIBA
10/2015
1Keratins (Keratin)IBA
01/2015
1trans-sodium crocetinate (crocetin)IBA
12/2014
1Messenger RNA (mRNA)IBA
12/2014
1RNA (Ribonucleic Acid)IBA
12/2014
1Formaldehyde (Formol)FDA Link
12/2014
1Small Interfering RNA (siRNA)IBA
01/2014
1Tight Junction ProteinsIBA
01/2014
1Claudin-1IBA
01/2014
1Tyrosine Kinase InhibitorsIBA
07/2011
1Epidermal Growth Factor (EGF)IBA
07/2011
1Gefitinib (Iressa)FDA Link
07/2011
1LigandsIBA
07/2011
1ProgesteroneFDA LinkGeneric
09/2010
1LeptinIBA
09/2010
1Complementary DNA (cDNA)IBA
09/2010
1Progesterone Receptors (Progesterone Receptor)IBA
09/2010
1Somatotropin Receptors (Growth Hormone Receptor)IBA
09/2010
1somatotropin releasing hormone receptorIBA
09/2010
1Estrogens (Estrogen)FDA Link
09/2010
1Nuclear Proteins (Protein, Nuclear)IBA
05/2010
1TenascinIBA
03/2010
1NestinIBA
03/2010
1VimentinIBA
03/2010
1CP 41IBA
03/2010
1Glial Fibrillary Acidic ProteinIBA
03/2010
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
03/2010

Therapy/Procedure

7Therapeutics
12/2017 - 12/2004
5Radiotherapy
12/2016 - 01/2002
5Operative Surgical Procedures
03/2014 - 11/2002
3Craniotomy
08/2004 - 02/2002
2Hypophysectomy
01/2008 - 06/2006
2Drug Therapy (Chemotherapy)
09/2005 - 05/2005
2Computer-Assisted Surgery (Image Guided Surgery)
04/2005 - 02/2003
1Combined Modality Therapy
10/2018
1Ventriculoperitoneal Shunt
06/2017
1Neurosurgical Procedures
01/2017
1Surgical Decompression
07/2015
1Patient Positioning
11/2013
1Aftercare (After-Treatment)
02/2012